SR-4835
Product Specifications
CAS Number
2387704-62-1
Target
CDK
Applications
Cell Cycle
Smiles
CN1C=C (C=N1) N2C=NC3=C (N=C (N=C32) N4CCOCC4) NCC5=NC6=CC (=C (C=C6N5) Cl) Cl
Molecular Formula
C21H20Cl2N10O
Additionnal Information
SR-4835 is a highly selective dual inhibitor of CDK12 and CDK13 with IC50 of 99 nM and Kd of 98 nM for CDK12 and IC50 of 4.9 nM for CDK13. SR-4835 disables triple-negative breast cancer (TNBC) cells. SR-4835 promotes synergy with DNA-damaging chemotherapy and PARP inhibitors.
Storage Conditions
3 years -20°C powder
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6263555-01 0.1 mL
Hepatitis B Surface Ag (HBsAg, Hepatitis B Surface) (MaxLight 405)
Sign In for Pricing
View Details MBS6263555-02 5x 0.1 mL
Hepatitis B Surface Ag (HBsAg, Hepatitis B Surface) (MaxLight 405)
Sign In for Pricing
View Details GR126115 100 µg
Genorise® Human Lambda Light Chain Monoclonal Antibody
Sign In for Pricing
View Details ![3-{5,7-Dioxo-5H,6H,7H-pyrrolo[3,4-b]pyrazin-6-yl}propanoic acid](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
BFA31028-01 0.5 g
3-{5,7-Dioxo-5H,6H,7H-pyrrolo[3,4-b]pyrazin-6-yl}propanoic acid
Sign In for Pricing
View Details BFA31028-02 5 g
3-{5,7-Dioxo-5H,6H,7H-pyrrolo[3,4-b]pyrazin-6-yl}propanoic acid
Sign In for Pricing
View Details